Priovant Therapeutics
Biotechnology, 151 W 42nd St, New York, 10036, United States, 11-50 Employees
Who is PRIOVANT THERAPEUTICS
Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens. We are rapidly developing ...
Read More
- Headquarters: 151 W 42nd St, New York, New York, 10036, United States
- Employees: 11-50
- Revenue: $10 Million to $25 Million
Industry: Biotechnology
SIC Code: 2834
Does something look wrong? Fix it. | View contact records from PRIOVANT THERAPEUTICS
Priovant Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Priovant Therapeutics
Answer: Priovant Therapeutics's headquarters are located at 151 W 42nd St, New York, 10036, United States
Answer: Priovant Therapeutics's official website is https://priovanttx.com
Answer: Priovant Therapeutics's revenue is $10 Million to $25 Million
Answer: Priovant Therapeutics's SIC: 2834
Answer: Priovant Therapeutics has 11-50 employees
Answer: Priovant Therapeutics is in Biotechnology
Answer: Priovant Therapeutics contact info: Phone number: Website: https://priovanttx.com
Answer: Priovant Therapeutics is a clinical-stage biotechnology company focused on delivering novel therapies for autoimmune diseases with the heaviest patient burdens. We are rapidly developing a pipeline of medicines targeted to the specific molecular dysregulations underlying severe autoimmune conditions, unlocking new treatment options for patients who are underserved by existing therapies.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month